![Paul Murray](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Paul Murray
Direktor/Vorstandsmitglied bei Ryboquin Co. Ltd.
Aktive Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Matthew Benson | M | 58 |
Ryboquin Co. Ltd.
![]() Ryboquin Co. Ltd. Pharmaceuticals: MajorHealth Technology Ryboquin Co. Ltd. provides pharmaceutical services. Its products include Ryboquin ECP-102 which is designed to make chemotherapy. The firm focused on commercialising patented technologies in the area of human cancer medicine. The company is headquartered in Selkirk, the United Kingdom. | 11 Jahre |
Alan Keith Walker | M | 80 |
Ryboquin Co. Ltd.
![]() Ryboquin Co. Ltd. Pharmaceuticals: MajorHealth Technology Ryboquin Co. Ltd. provides pharmaceutical services. Its products include Ryboquin ECP-102 which is designed to make chemotherapy. The firm focused on commercialising patented technologies in the area of human cancer medicine. The company is headquartered in Selkirk, the United Kingdom. | 11 Jahre |
Adrian Christopher Kirk | M | 62 |
Ryboquin Co. Ltd.
![]() Ryboquin Co. Ltd. Pharmaceuticals: MajorHealth Technology Ryboquin Co. Ltd. provides pharmaceutical services. Its products include Ryboquin ECP-102 which is designed to make chemotherapy. The firm focused on commercialising patented technologies in the area of human cancer medicine. The company is headquartered in Selkirk, the United Kingdom. | - |
Jonathan Douglas Lane | M | 64 |
Ryboquin Co. Ltd.
![]() Ryboquin Co. Ltd. Pharmaceuticals: MajorHealth Technology Ryboquin Co. Ltd. provides pharmaceutical services. Its products include Ryboquin ECP-102 which is designed to make chemotherapy. The firm focused on commercialising patented technologies in the area of human cancer medicine. The company is headquartered in Selkirk, the United Kingdom. | - |
Simon Paul Newman | M | 53 |
Ryboquin Co. Ltd.
![]() Ryboquin Co. Ltd. Pharmaceuticals: MajorHealth Technology Ryboquin Co. Ltd. provides pharmaceutical services. Its products include Ryboquin ECP-102 which is designed to make chemotherapy. The firm focused on commercialising patented technologies in the area of human cancer medicine. The company is headquartered in Selkirk, the United Kingdom. | - |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Statistik
Land | Beziehungen | % des Gesamten |
---|---|---|
Vereinigtes Königreich | 5 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Paul Murray
- Persönliches Netzwerk